|
C.QNTM
|
FSD Pharma announces the departure of Mr. David Urban from the Board of...
|
|
C.QNTM
|
The primary objective of the FSD201 COVID-19 Trial is to determine whether...
|
|
C.QNTM
|
The FSD201 COVID-19 Trial is a randomized, controlled, double-blind...
|
|
C.QNTM
|
SD Pharma this year transitioned from a focus on medical marijuana...
|
|
C.QNTM
|
The primary objective of the study is to determine whether FSD201 plus the...
|
|
C.QNTM
|
The new drug candidate, FSD201, is being developed to address the "over...
|
|
C.QNTM
|
chemical made from fat. It is found naturally in foods like egg yolks...
|
|
C.QNTM
|
Nano cap FSD Pharma (NASDAQ:HUGE) perks up 7% premarket...
|
|
C.QNTM
|
Pursuant to the Settlement Agreement, the Company will pay C$5,500,000...
|
|
C.QNTM
|
The Company entered into the Settlement Agreement in order to avoid the...
|
|
C.QNTM
|
"We are joining the global fight against the deadly SARS-CoV-2 virus...
|
|
C.QNTM
|
“Commencing a phase 2 clinical trial to treat hospitalized COVID-19 patients...
|
|
C.QNTM
|
Release results of Phase 2 study of FSD-201 Further study of drug to...
|
|
C.QNTM
|
Meanwhile, the company has strengthened its management team by...
|
|
C.QNTM
|
The company said the endpoint is "cytokine clearance" as measured...
|
|
C.QNTM
|
Secondary objectives include determining whether FSD-201 plus SOC...
|
|
C.QNTM
|
The primary objective of the trial is to determine whether FSD-201 plus SOC...
|
|
C.QNTM
|
It is designed to be a randomized, controlled, double-blind, multicenter...
|
|
C.QNTM
|
It also expects to get about $15 million for its shuttered, 600,000-square...
|
|
C.QNTM
|
In fact, the US Food and Drug Administration (FDA) has authorized the...
|